Molecular Templates, Inc. (MTEM)
Current
- (-)
After Hours
Rating Performance
Rating Return
+155.56% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+155.56% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+155.56% vs
Rating Accuracy
100.0% (1 of 1*)
Rating Return
+97.82% vs
Rating Accuracy
50.0% (2 of 4*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+531.89%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+467.54%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+307.3%
FV Accuracy
20 Hits (41.67% Hit Rate)
FV Avg. Distance
+178.86%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Eric E. Poma
Employees
168
Industry
Oncology Biopharmaceuticals
Sector
Healthcare
Headquarters
Austin
Exchange
NASDAQ
Website
http://www.mtem.comSummary Stats
Market Cap
55.6M
Revenue
44M
Net Income
-77.8M
EPS
-$1.38
Price-to-Earnings
-0.72
Price-to-Book
1.17
Debt-to-Equity
2.44
News
Analyst Ratings
Price targets projected by 6 analysts
High
$22.00
Average
$17.83
Low
$13.00
Ratings calculated by 8 analysts
Buy
8
Hold
0
Sell
0
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q1 2022
Not Available
-$0.38 -
-
-0.51
Up 25%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--